Professor Ajeet Singh is an academic private Psychiatrist based at The Geelong Clinic. He received his medical degree, masters, & doctorate from The University of Melbourne. His doctoral & post-doctoral work focussed on blood brain barrier Pharmacogenetics, he then founded a successful spinoff company CNSDose which won funding from The University of Melbourne and Texas Medical Centre before merging with a larger diagnostics firm. He is an author of the current and past RANZCP mood disorders clinical practice guidelines & is an adjunct Professor at Deakin Medical School.
Ajeet has over 100 academic publications and presentations, whilst remaining a fulltime clinician. He established the first regional clinical rTMS service in 2008 that continues to the present. He is an author of the forthcoming 2023 Clinical Pharmacogenetics Implementation Consortium (NIH) guidelines on antidepressants, and also served on the Genetics in Psychiatry taskforce for the International Society of Psychiatric Genetics. He remains committed to improving patient outcomes through scalable affordable mental health innovations and is currently developing artificial emotional intelligence systems for psychotherapy applications
Professor Singh has particular clinical interest in: